Pirtobrutinib, A Next Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results from the Phase 1/2 BRUIN Study

Wang, M., Shah, N. N., Alencar, A. J., Gerson, J. N., Patel, M. R., Fakhri, B., Jurczak, W., Tan, X. N., Lewis, K., Fenske, T. S., Coombs, C. C., Flinn, I. W., Lewis, D. J., Le Gouill, S., Palomba, M. L., Woyach, J. A., Pagel, J. M., Lamanna, N., Cohen, J. B., … Cheah, C. Y. (2021). Pirtobrutinib, A Next Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results from the Phase 1/2 BRUIN Study. Blood, 138(Supplement 1), 381–381. https://doi.org/10.1182/blood-2021-149138
Authors:
Michael Wang
Nirav N. Shah
Alvaro J. Alencar
James N. Gerson
Manish R. Patel
Bita Fakhri
Wojciech Jurczak
Xuan Tan
Katharine L. Lewis
Timothy S. Fenske
Catherine C. Coombs
Ian W. Flinn
David John Lewis
Steven Le Gouill
M. Lia Palomba
Jennifer A. Woyach
John M. Pagel
Nicole Lamanna
Jonathon B. Cohen
Minal Barve
Paolo Ghia
Toby A. Eyre
Pier Luigi Zinzani
Chaitra S. Ujjani
Youngil Koh
Koji Izutsu
Ewa Lech‐Marańda
Constantine S. Tam
Suchitra Sundaram
Ming Yin
Binoj C. Nair
Minna Balbas
Donald E. Tsai
Anthony R. Mato
Chan Y. Cheah
Affiliated Authors:
Nicole Lamanna
Columbia Affiliation:
Subjects:
Lymphoid Neoplasms (OpenAlex Topic)
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
Classification and Treatment of Cutaneous Lymphomas (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2021-149138
DOI:
10.1182/blood-2021-149138
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: